The Technical Analyst
Clarivate Plc [CLVT]
Exchange: NYSE Sector: Technology Industry: Information Technology Services
Clarivate Plc Price, Forecast, Insider, Ratings, Fundamentals & Signals
-11.37% $6.16
America/New_York / 8 mai 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 4 104.32 mill |
| EPS: | -1.470 |
| P/E: | -4.19 |
| Earnings Date: | May 08, 2024 |
| SharesOutstanding: | 666.29 mill |
| Avg Daily Volume: | 4.41 mill |
| RATING 2024-05-08 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Sell | |
| Return On Asset: | Sell | |
| DE: | Strong Buy | |
| P/E: | Sell | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -4.19 | sector: PE 13.21 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.19x |
| Company: PE -4.19 | industry: PE 21.50 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$13.46 (118.46%) $7.30 |
| Date: 2024-05-08 |
| Expected Trading Range (DAY) |
|---|
|
$ 5.91 - 6.41 ( +/- 4.12%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-05-07 | Heywood Suzanne | Buy | 23 741 | Ordinary Shares |
| 2024-05-07 | Heywood Suzanne | Buy | 0 | |
| 2024-05-07 | Alberola Valeria | Buy | 23 741 | Ordinary Shares |
| 2024-05-06 | Alberola Valeria | Sell | 2 647 | Ordinary Shares |
| 2024-05-07 | Roedel Richard | Buy | 23 741 | Ordinary Shares |
| INSIDER POWER |
|---|
| 71.45 |
| Last 94 transactions |
| Buy: 3 566 533 | Sell: 530 448 |
Forecast:
16:00 - $6.15
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $6.15
Forecast 2: 16:00 - $6.15
Forecast 3: 16:00 - $6.15
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $6.16 (-11.37% ) |
| Volume | 7.04 mill |
| Avg. Vol. | 4.41 mill |
| % of Avg. Vol | 159.65 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For CLVT
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
CLVT
Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.
Latest Press Releases
2024-05-08 06:00:00 - Press Release
Clarivate Reports First Quarter 2024 Results
— reaffirms 2024 outlook — london , may 8, 2024 /prnewswire/ -- clarivate plc (nyse: clvt) (the "company" or "clarivate"), a leading global provider of transformative intelligence, today reported results for the first quarter ended march 31, 2024. first quarter 2024 financial highlights revenues of $621.2 million decreased 1.3% organic revenues decreased 1.7%, as an increase in subscription revenues of 2.4% was more than offset by a decrease in transactional and other revenues of 11.4% and re-occurring revenues of 5.1% net loss attributable to ordinary shares of $93.8 million; net loss per diluted share of $0.14 adjusted net income(1) of $103.5 million decreased 20.9%; adjusted diluted eps(1) of $0...
2024-05-07 03:00:00 - Press Release
Clarivate Introduces Epidemiology Intelligence™ For Precision Patient Population Analysis
Empowering biopharma with unified epidemiology, incidence and prevalence data alongside claims-based population insights, for precise market sizing and patient population analysis london , may 7, 2024 /prnewswire/ -- clarivate plc (nyse: clvt), a leading global provider of transformative intelligence, today announced the launch of epidemiology intelligence™. the new solution combines rich insights from epidemiology, incidence and prevalence database solutions.
2024-05-02 03:00:00 - Press Release
Clarivate Enhances Cortellis Cmc Intelligence With Post-approval Module To Accelerate Regulatory Success
Enhancements enable pharma, biotech and generics companies to streamline regulatory tracking and optimize life cycle management for small molecules and biologics london , may 2, 2024 /prnewswire/ -- clarivate plc (nyse:clvt), a leading global provider of transformative intelligence, today announced the launch of the newly enhanced cortellis cmc intelligence™ solution, featuring a new post-approval variations module. the module for post-approval variations covers regulatory changes across multiple countries, offering meticulously curated requirements to streamline tracking.
2024-05-01 16:05:00 - Press Release
Clarivate Declares Dividend On Mandatory Convertible Preferred Shares
London , may 1, 2024 /prnewswire/ -- clarivate plc (nyse: clvt; clvt pr a) ("clarivate"), a leading global provider of transformative intelligence, today announced that its board of directors declared a quarterly dividend of $1.3125 per share on its 5.25% series a mandatory convertible preferred shares (the "preferred shares"), payable in cash on june 3, 2024 to shareholders of record at the close of business on may 15, 2024. on the mandatory conversion date, which is scheduled to occur on june 3, 2024, each preferred share will automatically and mandatorily convert into a number of ordinary shares of clarivate (and cash in lieu of any fractional ordinary shares) based on the average volume weighted average price ("vwap") of clarivate's ordinary shares over a 30-trading day period that begins on, and includes, april 18, 2024 and is scheduled to end on, and include, may 30, 2024 (the "valuation period").
2024-04-30 03:00:00 - Press Release
Bioworld By Clarivate Explores The Future Of Car T Therapy In Mainland China In Special Report
Three-part report investigates rapid pipeline growth, partnerships, clinical trials , and patient access challenges in cancer treatment london , april 30, 2024 /prnewswire/ -- bioworld™ published by clarivate plc (nyse:clvt), a leading global provider of transformative intelligence, explores the growing investment in car t therapy development in mainland china in a new series titled " china's car t market comes of age." the report examines the dynamic realm of car t-cell therapies in china, including the rapid pipeline growth, deals, clinical trials and challenging issues surrounding patient access to very expensive and effective cancer therapeutics.
Latest News
2024-05-08 10:36:35 - Zacks Investment Research
Compared to Estimates, Clarivate (CLVT) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Clarivate (CLVT) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
2024-05-08 08:15:26 - Zacks Investment Research
Clarivate PLC (CLVT) Q1 Earnings Meet Estimates
Clarivate PLC (CLVT) came out with quarterly earnings of $0.14 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.18 per share a year ago.
2024-05-01 11:05:39 - Zacks Investment Research
Clarivate PLC (CLVT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Clarivate (CLVT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2024-04-15 13:15:34 - Zacks Investment Research
Will Clarivate (CLVT) Beat Estimates Again in Its Next Earnings Report?
Clarivate (CLVT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
2024-03-01 23:18:10 - Seeking Alpha
Clarivate Plc (CLVT) Q4 2023 Earnings Call Transcript
2024-02-27 10:36:21 - Zacks Investment Research
Clarivate PLC (CLVT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Clarivate PLC (CLVT) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
2024-02-22 10:20:29 - Zacks Investment Research
Countdown to Clarivate PLC (CLVT) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Evaluate the expected performance of Clarivate PLC (CLVT) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
2023-12-17 21:32:02 - Seeking Alpha
Clarivate: Rating Upgrade As Organic Growth Turns Positive
Clarivate has turned organic growth positive and has visible tailwinds that could drive organic growth higher. The company reported positive organic growth in 3Q23, beating consensus estimates for revenue and EBITDA margins. The A&G and LSH segments showed strong organic growth, and the IP segment is expected to recover as macro headwinds ease.
2023-11-07 13:57:09 - Seeking Alpha
Clarivate Plc (CLVT) Q3 2023 Earnings Call Transcript
Clarivate Plc (NYSE:CLVT ) Q3 2023 Earnings Conference Call November 7, 2023 9:00 AM ET Company Participants Mark Donohue - Vice President, Investor Relations Jonathan Gear - Chief Executive Officer Jonathan Collins - Executive Vice President and Chief Financial Officer Conference Call Participants Toni Kaplan - Morgan Stanley Manav Patnaik - Barclays Surinder Thind - Jefferies Andrew Nicholas - William Blair John Mazzoni - Wells Fargo Owen Lau - Oppenheimer Ashish Sabadra - RBC Capital Markets Peter Christiansen - Citi George Tong - Goldman Sachs Operator Good morning. Thank you for attending today's Clarivate Third Quarter 2023 Earnings Call.
2023-11-07 08:16:09 - Zacks Investment Research
Clarivate PLC (CLVT) Beats Q3 Earnings and Revenue Estimates
Clarivate PLC (CLVT) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.20 per share a year ago.